The effect of ondansetron on the pharmacokinetics and pharmacodynamics of temazepam

Anaesthesia

Volumn 51, Issue 9, 1996, Pages 827-830

  Preston, G C ^a   Keene, O N ^a   Palmer, J L ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Hypnotics; benzodiazepine, temazepam; Pharmacodynamics; Pharmacokinetics; Vomiting; antiemetics, ondansetron

Indexed keywords

ANTIEMETIC AGENT; BENZODIAZEPINE DERIVATIVE; ONDANSETRON; TEMAZEPAM;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PREMEDICATION; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL;

EID: 0029815645     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2044.1996.tb12610.x     Document Type: Article

References (14)

1. PEARMAN MH. Single dose intravenous ondansetron in the prevention of postoperative nausea and vomiting. Anaesthesia 1994; 49 (suppl): 11-5.
2. RUST M, COHEN LA. Single oral dose ondansetron in the prevention of postoperative nausea and emesis. The European and US study groups. Anaesthesia 1994; 49 (Suppl): 16-23.
3. CLAYBOS L. Single dose intravenous ondansetron for the 24-hour treatment of postoperative nausea and vomiting. Anaesthesia 1994; 49 (suppl): 24-9.
4. JOSLYN A. Ondansetron, clinical development for postoperative nausea and vomiting: current studies and future directions. Anaesthesia 1994; 49 (Suppl): 34-7.
5. PALMER JL, FRAZER NM, KEENE ON, BABER NS. Tolerability and pharmacokinetics of intramuscular ondansetron 4 mg. Clinical Pharmacology and Therapeutics 1993; 53: 109.
6. COLTHUP PV, FELGATE CC, PALMFR JL, SCULLY NL. The determination of ondansetron in plasma and its pharmacokinetics in the young and elderly. Journal of Pharmaceutical Sciences 1991; 80: 868-71.
7. DIXON CM, COLTHUP PV, SEROBJIT-SINGH CJ, KERR BM, BOEHLERT CC, PARK GR, TARBIT MH. Multiple forms of cytochrome P450 are involved in the metabolism of ondansetron in man. Drug Metabolism and Disposition, 1995; 23: 1225-30.
8. RATCLIFF A, INDALO AA, BRADSHAW EG, RYE RM. Premedication with temazepam in minor surgery. The relationship between plasma concentration and clinical effect after a dose of 40 mg. Anaesthesia 1989; 44: 812-5.
9. BENET LZ, MASSOUD N, GAMBERTOGLIO JG. Pharmacokinetic basis for drug treatment. Raven Press, New York. 1985.
10. CARTWRIGHT AC. The March 1991 Barcelona Drug Information Association international concensus statement on bioavailability bioequivalence testing. Drug Information Journal 1991; 25: 474-82.
11. PABST G, JAEGER H. Review of methods and criteria for the evaluation of bioequivalence studies. European Journal of Clinical Pharmacology 1990; 38: 5-10.
12. HAUSCHKE D, STEINIJANS VW, DILETTI E. A distribution-free procedure for the statistical analysis of bioequivalence studies. International Journal of Clinical Pharmacology, Therapy and Toxicology 1990; 28: 72-8.
13. Guidance: Statistical procedures for bioequivalence studies using a standard two-treatment crossover design Office of Generic Drugs, Food and Drug Administration, Public Health Service, US Department of Health and Human Services, 1992.
14. JOCHEMSEN R, BRFIMER DD. Pharmacokinetics of temazepam compared with other benzodiazepine hypnotics some clinical consequences. Acta Phychiatrica Scandinavica Supplementum 1986; 332: 20-31.